Avondale Wealth Management’s AbbVie ABBV Stock Holding History

Avondale Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-40	Closed	-$4K	–	103
2021 Q3	$4K	Hold	40	–	–	﹤0.01%	103
2021 Q2	$5K	Hold	40	–	–	﹤0.01%	100
2021 Q1	$4K	Hold	40	–	–	﹤0.01%	95
2020 Q4	$4K	Hold	40	–	–	﹤0.01%	97
2020 Q3	$4K	Sell	40 -40	-50%	-$3.77K	0.01%	90
2020 Q2	$8K	Hold	80	–	–	0.01%	86
2020 Q1	$6K	Hold	80	–	–	0.01%	96
2019 Q4	$7K	Hold	80	–	–	0.01%	93
2019 Q3	$6K	Hold	80	–	–	0.01%	94
2019 Q2	$6K	Hold	80	–	–	﹤0.01%	101
2019 Q1	$6K	Sell	80 -22	-22%	-$1.8K	﹤0.01%	103
2018 Q4	$9K	Buy	102 +22	+28%	+$1.94K	0.01%	99
2018 Q3	$8K	Hold	80	–	–	0.01%	89
2018 Q2	$7K	Hold	80	–	–	0.01%	90
2018 Q1	$7K	Hold	80	–	–	0.01%	94
2017 Q4	$8K	Buy	+80	New	+$7.54K	0.01%	103

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Avondale Wealth Management's ABBV Position: Q4 2021 in Review

Avondale Wealth Management sold out of AbbVie (ABBV) in Q4 2021, closing a stake of 40 shares — an estimated $4K sold.

Avondale Wealth Management first reported a position in ABBV in Q4 2017 and held it in 16 quarters. The position peaked at $9K in Q4 2018. 2,981 funds tracked by Wall St. Rank hold ABBV as of Q4 2021.

Avondale Wealth Management reported no remaining AbbVie position as of Q4 2021 after selling out during the quarter.
Avondale Wealth Management sold 40 AbbVie shares in Q4 2021, an estimated $4K.
Avondale Wealth Management first reported a position in AbbVie in Q4 2017 and held it in 16 quarters.
Avondale Wealth Management's AbbVie position peaked at $9K in Q4 2018.
2,981 funds tracked by Wall St. Rank held AbbVie as of Q4 2021.

Based on Avondale Wealth Management's 13F filing for Q4 2021, filed 11 Jan 2022.